These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16977963)

  • 1. Medium and long-term outcome of growth hormone therapy in growth hormone deficient adults.
    Fideleff HL; Boquete H; Giaccio A; Sobrado P;
    Medicina (B Aires); 2006; 66(4):296-302. PubMed ID: 16977963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult growth hormone deficiency. Metabolic alterations and evaluation of different risk groups.
    Fideleff HL; Chervin A; Giaccio A; Sobrado P; Barmat R; Boquete H;
    Medicina (B Aires); 2004; 64(1):13-9. PubMed ID: 15034951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
    Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
    Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
    Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C
    Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
    Feldt-Rasmussen U; Wilton P; Jonsson P; ;
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The influence of long-term growth hormone replacement therapy on body composition, bone tissue and some metabolic parameters in adults with growth hormone deficiency].
    Olsovská V; Siprová H; Beránek M; Soska V
    Vnitr Lek; 2005 Dec; 51(12):1356-64. PubMed ID: 16430102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GH sensitivity of GH-deficient adults is dependent on gender but not timing of onset.
    Columb B; Smethurst LE; Mukherjee A; Jostel A; Shalet SM; Murray RD
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):281-6. PubMed ID: 18702681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group.
    Attanasio AF; Lamberts SW; Matranga AM; Birkett MA; Bates PC; Valk NK; Hilsted J; Bengtsson BA; Strasburger CJ
    J Clin Endocrinol Metab; 1997 Jan; 82(1):82-8. PubMed ID: 8989238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
    Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of IGF-I status in a large cohort of growth hormone-deficient (GHD) subjects: the role of timing of onset of GHD.
    Lissett CA; Jönsson P; Monson JP; Shalet SM;
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):773-8. PubMed ID: 14974921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status--3-year results from the HypoCCS Database.
    Attanasio AF; Bates PC; Ho KK; Webb SM; Ross RJ; Strasburger CJ; Bouillon R; Crowe B; Selander K; Valle D; Lamberts SW;
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1600-6. PubMed ID: 11932289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and treatment of adult growth hormone deficiency (aGHD) resulting from brain injury--role of aGHD].
    Arita K; Hirano H; Tominaga A; Kurisu K
    Brain Nerve; 2008 Dec; 60(12):1445-54. PubMed ID: 19110756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
    Gonc EN; Kandemir N
    Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased lipid peroxidation in growth hormone-deficient adult patients.
    Kokoszko A; Karbownik M; Lewiński A
    Neuro Endocrinol Lett; 2006; 27(1-2):225-30. PubMed ID: 16648797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of the adult growth hormone deficiency syndrome: directions for future research.
    Hoffman AR
    Growth Horm IGF Res; 2005 Jul; 15 Suppl A():48-52. PubMed ID: 16039888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of growth hormone treatment on B-type natriuretic peptide as a marker of heart failure in adults with growth hormone deficiency.
    Wallaschofski H; Saller B; Spilcke-Liss E; Lerch MM; Lohmann T; Eigenthaler M
    Horm Metab Res; 2006 Oct; 38(10):656-61. PubMed ID: 17075774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transition of childhood-onset growth hormone-deficient patients to adult healthcare.
    Rapaport R; Cook DM
    Pediatr Endocrinol Rev; 2006 Dec; 4 Suppl 1():82-90. PubMed ID: 17261975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reduction in visceral fat mass in response to growth hormone is more marked in men than in oestrogen-deficient women.
    Franco C; Koranyi J; Brandberg J; Lönn L; Bengtsson BK; Svensson J; Johannsson G
    Growth Horm IGF Res; 2009 Apr; 19(2):112-20. PubMed ID: 18752977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.